Pcgin

**Pcgin** is an engineered derivative of progranulin (PGRN) bearing the granulin E domain, developed as a chemically stable therapeutic agent for lysosomal storage disorders. It functions as a chaperone that binds to lysosomal enzymes such as beta-glucocerebrosidase (GBA) and hexosaminidase A (HexA), recruiting heat shock protein 70 (HSP70) to enhance their enzymatic activity, lysosomal delivery, and reduce substrate accumulation like glucocerebroside in Gaucher disease (GD) and GM2 ganglioside in Tay-Sachs disease (TSD). Studies in patient fibroblasts and progranulin-deficient mouse models demonstrate Pcgin reduces GBA clumping by up to 40%, GM2 storage, and associated pathologies; it also shows preliminary efficacy in reducing lung swelling in asthma models and potential blood-brain barrier penetration for neuropathic GD.[3][4][5][7][8]